Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience

McKay, S. C. et al. (2021) Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience. HPB, (doi: 10.1016/j.hpb.2021.03.003) (PMCID:PMC7973054) (In Press)

[img] Text
237219.pdf - Accepted Version
Restricted to Repository staff only until 19 March 2022.
Available under License Creative Commons Attribution Non-commercial No Derivatives.

781kB

Abstract

Introduction: The SARS-CoV-2 pandemic presented healthcare providers with an extreme challenge to provide cancer services. The impact upon the diagnostic and treatment capacity to treat pancreatic cancer is unclear. This study aimed to identify national variation in treatment pathways during the pandemic. Methods: A survey was distributed to all United Kingdom pancreatic specialist centres, to assess diagnostic, therapeutic and interventional services availability, and alterations in treatment pathways. A repeating methodology enabled assessment over time as the pandemic evolved. Results: Responses were received from all 29 centres. Over the first six weeks of the pandemic, less than a quarter of centres had normal availability of diagnostic pathways and a fifth of centres had no capacity whatsoever to undertake surgery. As the pandemic progressed services have gradually improved though most centres remain constrained to some degree. One third of centres changed their standard resectable pathway from surgery-first to neoadjuvant chemotherapy. Elderly patients, and those with COPD were less likely to be offered treatment during the pandemic. Conclusion: The COVID-19 pandemic has affected the capacity of the NHS to provide diagnostic and staging investigations for pancreatic cancer. The impact of revised treatment pathways has yet to be realised.

Item Type:Articles
Keywords:Pancreatice cancer, SARS-CoV-2.
Status:In Press
Refereed:Yes
Glasgow Author(s) Enlighten ID:Jamieson, Dr Nigel
Authors: McKay, S. C., Pathak, S., Wilkin, R. J.W., Kamarajah, S. K., Wigmore, S. J., Rees, J., Dunne, D. F.J., Garcea, G., Ahmad, J., de Liguori Carino, N., Sultana, A., Silva, M., Lykoudis, P., Nasralla, D., Milburn, J., Shah, N., Kocher, H. M., Bhogal, R., Baron, R. D., Navarro, A., Halle-Smith, J., Al-Sarireh, B., Sen, G., Jamieson, N. B., Briggs, C., Stell, D., Aroori, S., Bowles, M., Kanwar, A., Harper, S., Menon, K., Prachalias, A., Srinivasan, P., Frampton, A. E., Jones, C., Arshad, A., Tait, I., Spalding, D., Young, A. L., Durkin, D., Ghods-Ghorbani, M., Sutcliffe, R. P., and Roberts, K.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
Journal Name:HPB
Publisher:Elsevier
ISSN:1365-182X
ISSN (Online):1477-2574
Published Online:19 March 2021
Copyright Holders:Copyright © 2021 Elsevier Ltd.
First Published:First published in HPB 2021
Publisher Policy:Reproduced in accordance with the publisher copyright policy

University Staff: Request a correction | Enlighten Editors: Update this record